Michael Kraus is a Nephrology physician affiliated with Indiana University Bloomington. OpenAlex indexes 100 publications with 3,529 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1701 N Senate Blvd
Indianapolis, IN 462021239
Telephone
888-484-3258Provider last certified this registry record 15 Mar 2025.
Clinical trials
- Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy
Sponsor: University of Wuerzburg
- Phosphorus and Calcium Removal During Long Hemodialysis Treatment Sessions
Sponsor: Indiana University
- Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C
Sponsor: University of Wuerzburg
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CorMedix Inc.Program year20256 payments$88,797openpaymentsdata.cms.gov ↗
- NXSTAGE MEDICAL, INC.Program year20246 payments
- Fresenius USA Marketing, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%alpha-Adrenergic Blocker100%Doxazosin Mesylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1999–1999 per NIH RePORTER. The latest:
- TERBUTALINE INDUCED HYPOKALEMIA IN END STAGE RENAL DISEASE
Indiana Univ-Purdue Univ at Indianapolis
FY1999M01RR000750
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Trends in Automated Peritoneal Dialysis Prescriptions in a Large Dialysis Organization in the United States
Clinical Journal of the American Society of Nephrology
2024 - Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine
Clinical Kidney Journal
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”